| 1 | Multiple Pulmonary Nodules | 41.4% |
| 2 | Pleural Neoplasms | 35.4% |
| 3 | Tracheal Neoplasms | 33.9% |
| 4 | Bronchitis | 30.8% |
| 5 | Tracheobronchomegaly | 28.5% |
| 6 | Bronchopneumonia | 28.2% |
| 7 | Asthma | 26.2% |
| 8 | Bronchospasm | 25.5% |
| 9 | Bronchiectasis | 25.5% |
| 10 | Bronchial Hyperreactivity | 25.5% |
| 11 | Pleural Effusion, Malignant | 25.1% |
| 12 | Bronchial Fistula | 24.9% |
| 13 | Bronchitis, Chronic | 22.7% |
| 14 | Bronchiolitis | 22.2% |
| 15 | Lung diseases | 19.4% |
| 16 | Pleural Diseases | 19.4% |
| 17 | Respiration Disorders | 19.4% |
| 18 | Thoracic Diseases | 19.4% |
| 19 | Tracheal Diseases | 19.4% |
| 20 | Pleurisy | 19.2% |
| 21 | Pneumonia | 19.2% |
| 22 | Lobar Pneumonia | 19.2% |
| 23 | Respiratory Distress Syndrome, Adult | 19.2% |
| 24 | Tracheitis | 19.2% |
| 25 | Pneumonitis | 19.2% |
| 26 | Laryngeal neoplasm | 19.1% |
| 27 | Pleuropneumonia | 19.1% |
| 28 | Asthma, Exercise-Induced | 17.7% |
| 29 | Status Asthmaticus | 17.7% |
| 30 | Nose Neoplasms | 16.6% |
| 31 | Bronchiolitis Obliterans | 16.4% |
| 32 | Granuloma, Laryngeal | 16.2% |
| 33 | Laryngitis | 16.1% |
| 34 | Lung Diseases, Fungal | 16.1% |
| 35 | Rhinitis | 16.1% |
| 36 | Vocal Cord Dysfunction | 16.1% |
| 37 | Laryngeal Diseases | 16% |
| 38 | Nose Diseases | 16% |
| 39 | Respiratory Distress Syndrome, Newborn | 16% |
| 40 | Lung Abscess | 15.9% |
| 41 | Tuberculosis, Pulmonary | 15.8% |
| 42 | Asthma, Occupational | 15.6% |
| 43 | Respiratory Tract Infections | 15.5% |
| 44 | Granuloma, Respiratory Tract | 15.3% |
| 45 | Respiratory Hypersensitivity | 15.3% |
| 46 | Respiratory Tract Fistula | 15.3% |
| 47 | Choanal Atresia | 13.8% |
| 48 | Laryngocele | 13.8% |
| 49 | Paranasal Sinus Neoplasms | 13.6% |
| 50 | Sinusitis | 13.5% |
| 51 | Aspiration Pneumonia | 13.4% |
| 52 | Asthma, Aspirin-Induced | 13.4% |
| 53 | Aspergillosis, Allergic Bronchopulmonary | 13.3% |
| 54 | Lung Neoplasms | 12.5% |
| 55 | Idiopathic Pulmonary Fibrosis | 12% |
| 56 | Altitude Sickness | 11.9% |
| 57 | Atelectasis | 11.9% |
| 58 | Chylothorax | 11.9% |
| 59 | Hydropneumothorax | 11.9% |
| 60 | Hydrothorax | 11.9% |
| 61 | Pulmonary Hypertension | 11.9% |
| 62 | Pneumothorax | 11.9% |
| 63 | Pulmonary Alveolar Proteinosis | 11.9% |
| 64 | Pulmonary Edema | 11.9% |
| 65 | Pulmonary Fibrosis | 11.9% |
| 66 | Respiratory Insufficiency | 11.9% |
| 67 | Tracheal Stenosis | 11.9% |
| 68 | Hamman-Rich syndrome | 11.9% |
| 69 | Lung Diseases, Interstitial | 11.9% |
| 70 | Respiratory Depression | 11.9% |
| 71 | Lung Diseases, Obstructive | 11.9% |
| 72 | Respiratory Failure | 11.9% |
| 73 | Thymus Neoplasms | 11.9% |
| 74 | Pneumoconiosis | 11.5% |
| 75 | Pneumonia, Viral | 11.5% |
| 76 | Abdominal Neoplasms | 11.5% |
| 77 | Head and Neck Neoplasms | 11.5% |
| 78 | Soft Tissue Neoplasms | 11.5% |
| 79 | Pneumonia, Bacterial | 11.3% |
| 80 | Kartagener Syndrome | 11.1% |
| 81 | Laryngospasm | 11.1% |
| 82 | Primary Ciliary Dyskinesia | 11.1% |
| 83 | Hyaline Membrane Disease | 11.1% |
| 84 | Scimitar Syndrome | 10.6% |
| 85 | Pneumonia, Lipid | 10.6% |
| 86 | Maxillary Sinus Neoplasms | 10.5% |
| 87 | Bronchomalacia | 10.4% |
| 88 | Acute Chest Syndrome | 10.4% |
| 89 | Meconium Aspiration Syndrome | 10.3% |
| 90 | Mediastinal Cyst | 9.8% |
| 91 | Pericardial Cyst | 9.8% |
| 92 | Thymic Cyst | 9.8% |
| 93 | Granuloma, Lethal Midline | 9.6% |
| 94 | Laryngeal Edema | 9.6% |
| 95 | Nose Deformities, Acquired | 9.6% |
| 96 | Lung Injury | 9.6% |
| 97 | Hepatopulmonary Syndrome | 9.6% |
| 98 | Respiratory Aspiration | 9.6% |
| 99 | Radiation Pneumonitis | 9.6% |
| 100 | Radiation Fibrosis | 9.6% |
| 101 | Digestive System Neoplasms | 9.5% |
| 102 | Endocrine Gland Neoplasms | 9.5% |
| 103 | Eye Neoplasms | 9.5% |
| 104 | Nervous System Neoplasms | 9.5% |
| 105 | Apnea | 9.5% |
| 106 | Cheyne-Stokes Respiration | 9.5% |
| 107 | Common Cold | 9.5% |
| 108 | Dyspnea | 9.5% |
| 109 | Hemothorax | 9.5% |
| 110 | Hyperventilation | 9.5% |
| 111 | Influenza | 9.5% |
| 112 | Mouth Breathing | 9.5% |
| 113 | Tachypnea | 9.5% |
| 114 | Catarrh | 9.5% |
| 115 | Pulmonary Embolism | 9.4% |
| 116 | Rhinoscleroma | 9.4% |
| 117 | Pulmonary Eosinophilia | 9.4% |
| 118 | Severe Acute Respiratory Syndrome | 9.4% |
| 119 | Eosinophilic Pneumonia | 9.4% |
| 120 | Laryngopharyngeal Reflux | 9.4% |
| 121 | Bone neoplasms | 9.3% |
| 122 | Skin Neoplasms | 9.3% |
| 123 | Hematologic Neoplasms | 9.3% |
| 124 | Splenic Neoplasms | 9.2% |
| 125 | Hoarseness | 8.9% |
| 126 | Asbestosis | 8.9% |
| 127 | Berylliosis | 8.9% |
| 128 | Silicosis | 8.9% |
| 129 | Bronchial Diseases | 8.8% |
| 130 | Farmer's Lung | 8.6% |
| 131 | Hay fever | 8.5% |
| 132 | Rhinitis, Allergic, Perennial | 8.5% |
| 133 | Airway Obstruction | 8.4% |
| 134 | Choking | 8.4% |
| 135 | Epiglottitis | 8.4% |
| 136 | Chronic Obstructive Airway Disease | 8.4% |
| 137 | Mediastinitis | 8.4% |
| 138 | Middle Lobe Syndrome | 8.4% |
| 139 | Acute Lung Injury | 8.4% |
| 140 | Pharyngitis | 8.1% |
| 141 | Laryngostenosis | 8% |
| 142 | Nasal Polyps | 8% |
| 143 | Hemoptysis | 7.9% |
| 144 | Pertussis | 7.8% |
| 145 | Hamartoma | 7.5% |
| 146 | Neoplasms, Hormone-Dependent | 7.5% |
| 147 | Neoplasms, Multiple Primary | 7.5% |
| 148 | Paraneoplastic Syndromes | 7.5% |
| 149 | Precancerous Conditions | 7.5% |
| 150 | Neoplasms, Second Primary | 7.5% |
| 151 | Blastomycosis | 7.4% |
| 152 | Parathyroid Neoplasms | 7.3% |
| 153 | Peritoneal Neoplasms | 7.3% |
| 154 | Thyroid Neoplasm | 7.3% |
| 155 | Thyroid carcinoma | 7.3% |
| 156 | Thymoma | 7.2% |
| 157 | Multiple Endocrine Neoplasia | 7.1% |
| 158 | Cystic Fibrosis | 6.9% |
| 159 | Voice Disorders | 6.9% |
| 160 | Voice Disturbance | 6.9% |
| 161 | Paraneoplastic Encephalomyelitis | 6.8% |
| 162 | Epistaxis | 6.8% |
| 163 | Persistent Fetal Circulation Syndrome | 6.8% |
| 164 | Mammary Neoplasms, Experimental | 6.7% |
| 165 | Bronchial Neoplasms | 6.7% |
| 166 | Croup | 6.7% |
| 167 | Histiocytosis, Langerhans-Cell | 6.7% |
| 168 | Mediastinal Emphysema | 6.7% |
| 169 | Rhinitis, Vasomotor | 6.7% |
| 170 | Pulmonary Aspergillosis | 6.7% |
| 171 | Bronchopulmonary Aspergillosis | 6.7% |
| 172 | Hypoventilation | 6.7% |
| 173 | Acidosis, Respiratory | 6.6% |
| 174 | Alkalosis, Respiratory | 6.6% |
| 175 | Sarcoidosis, Pulmonary | 6.6% |
| 176 | Sleep Apnea Syndromes | 6.6% |
| 177 | Pulmonary Emphysema | 6.6% |
| 178 | Pulmonary Infarction | 6.6% |
| 179 | Pancreatic Neoplasm | 6.4% |
| 180 | Retroperitoneal Neoplasms | 6.3% |
| 181 | Cyst | 6% |
| 182 | Neoplastic Processes | 6% |
| 183 | Neoplastic Syndromes, Hereditary | 6% |
| 184 | Pregnancy Complications, Neoplastic | 6% |
| 185 | Laryngomalacia | 6% |
| 186 | Acanthoma | 6% |
| 187 | Neoplasms, Experimental | 5.9% |
| 188 | Vocal Cord Paralysis | 5.9% |
| 189 | Tonsillitis | 5.6% |
| 190 | Dyspnea, Paroxysmal | 5.5% |
| 191 | Respiratory Paralysis | 5.5% |
| 192 | Granulomatosis with polyangiitis | 5.5% |
| 193 | Bronchopulmonary Dysplasia | 5.3% |
| 194 | Sleep Apnea, Obstructive | 5.3% |
| 195 | Sleep Apnea, Central | 5.3% |
| 196 | Mouth Neoplasms | 5.1% |
| 197 | Central Nervous System Neoplasms | 5.1% |
| 198 | Vascular Neoplasms | 5.1% |
| 199 | Genital Neoplasms, Female | 5% |
| 200 | Esophageal Neoplasms | 5% |
| 201 | Breast Neoplasms, Male | 5% |
| 202 | Triple Negative Breast Neoplasms | 5% |
| 203 | Neoplasms, Radiation-Induced | 4.9% |
| 204 | Aphonia | 4.8% |
| 205 | Retropharyngeal Abscess | 4.8% |
| 206 | Dysphonia | 4.8% |
| 207 | Anti-Glomerular Basement Membrane Disease | 4.7% |
| 208 | Tracheomalacia | 4.7% |
| 209 | Carcinoma, Lobular | 4.7% |
| 210 | Transfusion-Related Acute Lung Injury | 4.5% |
| 211 | Testicular Neoplasms | 4.5% |
| 212 | Invasive Pulmonary Aspergillosis | 4.4% |
| 213 | Adrenal Gland Neoplasms | 4.3% |
| 214 | Gastrointestinal Neoplasms | 4.3% |
| 215 | Genital Neoplasms, Male | 4.3% |
| 216 | Liver neoplasms | 4.3% |
| 217 | Uveal Neoplasms | 4.3% |
| 218 | Thyroid Nodule | 4.3% |
| 219 | Urologic Neoplasms | 4.2% |
| 220 | Sebaceous Gland Neoplasms | 4.2% |
| 221 | Spinal Neoplasms | 4.2% |
| 222 | Bone Marrow Neoplasms | 4.2% |
| 223 | Nasopharyngitis | 4.2% |
| 224 | Carcinoma, Ehrlich Tumor | 4% |
| 225 | Dermoid Cyst | 4% |
| 226 | Carcinoma, Lewis Lung | 4% |
| 227 | Trophoblastic Neoplasms | 3.9% |
| 228 | Multiple Endocrine Neoplasia Type 1 | 3.9% |
| 229 | Leukemia, Experimental | 3.9% |
| 230 | Carcinoma 256, Walker | 3.9% |
| 231 | Erythroplasia | 3.8% |
| 232 | Follicular cyst | 3.8% |
| 233 | leukemia | 3.8% |
| 234 | Mucocele | 3.8% |
| 235 | Neoplasms, Germ Cell and Embryonal | 3.8% |
| 236 | Neoplasms, Glandular and Epithelial | 3.8% |
| 237 | Pilonidal Cyst | 3.8% |
| 238 | Thyroglossal Cyst | 3.8% |
| 239 | Synovial Cyst | 3.8% |
| 240 | Germ Cell Cancer | 3.8% |
| 241 | Aberrant Crypt Foci | 3.8% |
| 242 | Tuberous Sclerosis | 3.8% |
| 243 | Meningioma | 3.8% |
| 244 | Liver Neoplasms, Experimental | 3.8% |
| 245 | Peritonsillar Abscess | 3.7% |
| 246 | Carcinoma, Pancreatic Ductal | 3.5% |
| 247 | Leukemia, Radiation-Induced | 3.4% |
| 248 | Neuroectodermal Tumors | 3.3% |
| 249 | Sarcoma, Experimental | 3.3% |
| 250 | Eosinophilic Granuloma | 3.3% |
| 251 | Leukoplakia, Oral | 3.3% |
| 252 | Paraneoplastic Cerebellar Degeneration | 3.3% |
| 253 | ovarian neoplasm | 3.1% |
| 254 | Leukoplakia | 3.1% |
| 255 | Lymphocele | 3.1% |
| 256 | Pancreatic Cyst | 3.1% |
| 257 | Melanoma, Experimental | 3.1% |
| 258 | Barrett Esophagus | 3.1% |
| 259 | Breast Cyst | 3.1% |
| 260 | Histiocytic Disorders, Malignant | 3.1% |
| 261 | Actinic keratosis | 3.1% |
| 262 | Neoplasm Invasiveness | 3.1% |
| 263 | Neoplasm Metastasis | 3.1% |
| 264 | Neoplasm Recurrence, Local | 3.1% |
| 265 | Parovarian Cyst | 3.1% |
| 266 | Carcinogenesis | 3.1% |
| 267 | Myxoid cyst | 3.1% |
| 268 | Metastasis | 3.1% |
| 269 | Neoplasms, Neuroepithelial | 3% |
| 270 | Gliomatosis cerebri | 3% |
| 271 | Nephroblastoma | 3% |
| 272 | Meningeal Neoplasms | 3% |
| 273 | Limbic Encephalitis | 2.9% |
| 274 | Hepatocellular Adenoma | 2.8% |
| 275 | Pituitary Adenoma | 2.8% |
| 276 | Pituitary Neoplasms | 2.8% |
| 277 | Palatal Neoplasms | 2.7% |
| 278 | Acoustic Neuroma | 2.7% |
| 279 | Carcinosarcoma | 2.7% |
| 280 | Hemangiosarcoma | 2.7% |
| 281 | Leukemia L1210 | 2.7% |
| 282 | Leukemia P388 | 2.7% |
| 283 | lymphangiosarcoma | 2.7% |
| 284 | Retinoblastoma | 2.6% |
| 285 | Lambert-Eaton Myasthenic Syndrome | 2.6% |
| 286 | Lymphomatoid Granulomatosis | 2.6% |
| 287 | Ear Neoplasms | 2.5% |
| 288 | Eyelid Neoplasms | 2.5% |
| 289 | Lymphoma | 2.5% |
| 290 | insulinoma | 2.5% |
| 291 | Corpus Luteum Cyst | 2.5% |
| 292 | Ovarian Cysts | 2.5% |
| 293 | Brain Neoplasms | 2.5% |
| 294 | Salivary Gland Neoplasms | 2.5% |
| 295 | Spinal Cord Neoplasms | 2.5% |
| 296 | Tongue Neoplasms | 2.5% |
| 297 | Prolactinoma | 2.5% |
| 298 | Growth Hormone-Secreting Pituitary Adenoma | 2.5% |
| 299 | melanoma | 2.5% |
| 300 | Uterine Neoplasms | 2.5% |
| 301 | Vaginal Neoplasms | 2.5% |
| 302 | Vulvar Neoplasms | 2.5% |
| 303 | Uterine Cancer | 2.5% |
| 304 | Fallopian Tube Neoplasms | 2.5% |
| 305 | Gastrinoma | 2.4% |
| 306 | Glucagonoma | 2.4% |
| 307 | Vipoma | 2.4% |
| 308 | Composite Lymphoma | 2.4% |
| 309 | Choriocarcinoma | 2.3% |
| 310 | Opsoclonus-Myoclonus Syndrome | 2.3% |
| 311 | Sarcoma 180 | 2.3% |
| 312 | Leukemia, Plasma Cell | 2.2% |
| 313 | Pharyngeal Neoplasms | 2.2% |
| 314 | Choledochal Cyst | 2.2% |
| 315 | granulosa cell tumor | 2.2% |
| 316 | Carcinoma, Ovarian Epithelial | 2.2% |
| 317 | Central Nervous System Cysts | 2.2% |
| 318 | Peutz-Jeghers Syndrome | 2.1% |
| 319 | Bile Duct Neoplasms | 2.1% |
| 320 | gallbladder neoplasm | 2.1% |
| 321 | Intestinal Neoplasms | 2.1% |
| 322 | Penile Neoplasms | 2.1% |
| 323 | Prostatic Neoplasms | 2.1% |
| 324 | Stomach Neoplasms | 2.1% |
| 325 | Polycythemia Vera | 2.1% |
| 326 | Adenomatous Polyposis Coli | 2.1% |
| 327 | Myelitis, Transverse | 2.1% |
| 328 | Adenoma | 2.1% |
| 329 | Ameloblastoma | 2.1% |
| 330 | Angiokeratoma | 2.1% |
| 331 | Carcinoma | 2.1% |
| 332 | Chordoma | 2.1% |
| 333 | Hemangioma | 2.1% |
| 334 | hemangiopericytoma | 2.1% |
| 335 | Lymphangioma | 2.1% |
| 336 | Mesenchymoma | 2.1% |
| 337 | Nevus | 2.1% |
| 338 | Teratoma | 2.1% |
| 339 | Hepatoblastoma | 2.1% |
| 340 | Mixed Tumor, Mullerian | 2.1% |
| 341 | Germinoma | 2.1% |
| 342 | Teratocarcinoma | 2.1% |
| 343 | Angiofibroma | 2.1% |
| 344 | Sarcoma | 2.1% |
| 345 | Epithelioma | 2.1% |
| 346 | Basal Cell Nevus Syndrome | 2.1% |
| 347 | Leydig Cell Tumor | 2% |
| 348 | Mesoblastic Nephroma | 2% |
| 349 | Basal cell carcinoma | 2% |
| 350 | Carcinoma, Papillary | 2% |
| 351 | Squamous cell carcinoma | 2% |
| 352 | Chondrosarcoma | 2% |
| 353 | Craniopharyngioma | 2% |
| 354 | Cystadenoma | 2% |
| 355 | leiomyosarcoma | 2% |
| 356 | liposarcoma | 2% |
| 357 | Mesothelioma | 2% |
| 358 | synovial sarcoma | 2% |
| 359 | Neuroectodermal Tumor, Melanotic | 2% |
| 360 | Angiomyolipoma | 2% |
| 361 | Clear Cell Sarcoma of Soft Tissue | 2% |
| 362 | Alveolar Soft Part Sarcoma | 2% |
| 363 | Neuroendocrine Tumors | 2% |
| 364 | Sarcoma, Myeloid | 2% |
| 365 | Carcinoma, Basal Cell | 2% |
| 366 | Meningeal Carcinomatosis | 2% |
| 367 | Optic Nerve Glioma | 1.9% |
| 368 | Adenoma, Acidophil | 1.9% |
| 369 | Ganglioneuroma | 1.9% |
| 370 | Glioma | 1.9% |
| 371 | Malignant Glioma | 1.9% |
| 372 | Bladder Neoplasm | 1.9% |
| 373 | Kidney Neoplasm | 1.9% |
| 374 | Ureteral Neoplasms | 1.9% |
| 375 | Urethral Neoplasms | 1.9% |
| 376 | Medulloblastoma | 1.8% |
| 377 | Pancreatic Pseudocyst | 1.7% |
| 378 | Plasmacytoma | 1.7% |
| 379 | Malignant histiocytosis | 1.7% |
| 380 | Lymphatic Metastasis | 1.7% |
| 381 | Neoplasms, Unknown Primary | 1.7% |
| 382 | Leukemic Infiltration | 1.7% |
| 383 | Histiocytic sarcoma | 1.7% |
| 384 | Neoplasm Micrometastasis | 1.7% |
| 385 | Cystadenocarcinoma | 1.6% |
| 386 | Fibrosarcoma | 1.6% |
| 387 | Osteosarcoma | 1.6% |
| 388 | Mucoepidermoid Carcinoma | 1.6% |
| 389 | Supratentorial Neoplasms | 1.6% |
| 390 | Carcinoid Tumor | 1.6% |
| 391 | Endometrial Neoplasms | 1.6% |
| 392 | Neurilemmoma | 1.6% |
| 393 | Hutchinson's Melanotic Freckle | 1.6% |
| 394 | Melanoma, Amelanotic | 1.6% |
| 395 | Endometrial Stromal Sarcoma | 1.6% |
| 396 | Adrenocortical carcinoma | 1.6% |
| 397 | Adenofibroma | 1.5% |
| 398 | Fibroadenoma | 1.5% |
| 399 | Malignant Fibrous Histiocytoma | 1.5% |
| 400 | Renal Cell Carcinoma | 1.4% |
| 401 | Papillary Renal Cell Carcinoma | 1.4% |
| 402 | Hypopharyngeal Neoplasms | 1.4% |
| 403 | Hypopharyngeal Cancer | 1.4% |
| 404 | Lymphangioleiomyomatosis | 1.4% |
| 405 | Parotid Neoplasms | 1.4% |
| 406 | Prostatic Neoplasms, Castration-Resistant | 1.4% |
| 407 | Nelson Syndrome | 1.4% |
| 408 | Hodgkin Disease | 1.4% |
| 409 | Lymphoma, Non-Hodgkin | 1.4% |
| 410 | Xeroderma Pigmentosum | 1.4% |
| 411 | Polycystic Ovary Syndrome | 1.4% |
| 412 | Hydatidiform Mole | 1.4% |
| 413 | Astrocytoma | 1.4% |
| 414 | Ependymoma | 1.4% |
| 415 | oligodendroglioma | 1.4% |
| 416 | Ganglioglioma | 1.4% |
| 417 | gliosarcoma | 1.4% |
| 418 | Anaplastic astrocytoma | 1.4% |
| 419 | Anaplastic Oligodendroglioma | 1.4% |
| 420 | Denys-Drash Syndrome | 1.3% |
| 421 | Bowen's Disease | 1.3% |
| 422 | Paraganglioma | 1.3% |
| 423 | Rhabdomyosarcoma | 1.3% |
| 424 | Giant Cell Tumor of Bone | 1.3% |
| 425 | Adenocarcinoma | 1.2% |
| 426 | Carcinoma in Situ | 1.2% |
| 427 | Carcinoma, Transitional Cell | 1.2% |
| 428 | Phyllodes Tumor | 1.2% |
| 429 | Dysgerminoma | 1.2% |
| 430 | Hemangioendothelioma | 1.2% |
| 431 | Lipoma | 1.2% |
| 432 | Myoma | 1.2% |
| 433 | Myxoma | 1.2% |
| 434 | Neuroma | 1.2% |
| 435 | Papilloma | 1.2% |
| 436 | Pseudomyxoma Peritonei | 1.2% |
| 437 | Seminoma | 1.2% |
| 438 | Papillomatosis | 1.2% |
| 439 | Angiolipoma | 1.2% |
| 440 | Myelolipoma | 1.2% |
| 441 | Neoplasms, Bone Tissue | 1.2% |
| 442 | Neoplasms, Fibrous Tissue | 1.2% |
| 443 | Smooth Muscle Tumor | 1.2% |
| 444 | Adenomatosis, Pulmonary | 1.2% |
| 445 | Adenomatous Polyps | 1.2% |
| 446 | Carcinoma, Large Cell | 1.2% |
| 447 | Carcinoma, Small Cell | 1.2% |
| 448 | Desmoplastic Small Round Cell Tumor | 1.2% |
| 449 | Chondroma | 1.2% |
| 450 | Enchondroma | 1.2% |
| 451 | Cecal Neoplasms | 1.2% |
| 452 | Duodenal Neoplasms | 1.2% |
| 453 | Brain Stem Neoplasms | 1.2% |
| 454 | Nasopharyngeal carcinoma | 1.2% |
| 455 | Malignant Carcinoid Syndrome | 1.2% |
| 456 | Primary amyloidosis | 1.2% |
| 457 | Carcinoma, Endometrioid | 1.2% |
| 458 | Dermatofibrosarcoma | 1.1% |
| 459 | Dermatofibrosarcoma Protuberans | 1.1% |
| 460 | Neurofibrosarcoma | 1.1% |
| 461 | Nasopharyngeal Neoplasms | 1.1% |
| 462 | Colorectal Neoplasms | 1.1% |
| 463 | Glioblastoma | 1.1% |
| 464 | Neuroblastoma | 1.1% |
| 465 | Glioblastoma Multiforme | 1.1% |
| 466 | Tonsillar Neoplasms | 1.1% |
| 467 | Cerebellar Neoplasms | 1% |
| 468 | Choroid Plexus Papilloma | 1% |
| 469 | Leukemia, Myelomonocytic, Chronic | 1% |
| 470 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1% |
| 471 | Pheochromocytoma | 1% |
| 472 | Alveolar rhabdomyosarcoma | 1% |
| 473 | Ganglioneuroblastoma | 0.9% |
| 474 | Waldenstrom Macroglobulinemia | 0.9% |
| 475 | Multiple Myeloma | 0.9% |
| 476 | Appendiceal Neoplasms | 0.9% |
| 477 | Colonic Neoplasms | 0.9% |
| 478 | Rectal Neoplasms | 0.9% |
| 479 | Carcinoid Heart Disease | 0.9% |
| 480 | Mastocytosis | 0.8% |
| 481 | Sturge-Weber Syndrome | 0.8% |
| 482 | Cell Transformation, Viral | 0.8% |
| 483 | Gastrointestinal Stromal Tumors | 0.8% |
| 484 | Zollinger-Ellison syndrome | 0.8% |
| 485 | Adenoid Cystic Carcinoma | 0.8% |
| 486 | fibroma | 0.8% |
| 487 | Fibromatosis | 0.8% |
| 488 | Hemangioma, Cavernous | 0.8% |
| 489 | Osteoblastoma | 0.8% |
| 490 | Osteoma | 0.8% |
| 491 | Rhabdomyoma | 0.8% |
| 492 | Chondromatosis | 0.8% |
| 493 | Adenocarcinoma, Clear Cell | 0.8% |
| 494 | Cholangiocarcinoma | 0.8% |
| 495 | Cervical Intraepithelial Neoplasia | 0.8% |
| 496 | Hemangioblastoma | 0.8% |
| 497 | Lymphoma, Extranodal NK-T-Cell | 0.8% |
| 498 | Leukemia, T-Cell | 0.8% |
| 499 | Leukemia, B-Cell | 0.8% |
| 500 | neurofibroma | 0.8% |
| 501 | Lymphoma, Follicular | 0.8% |
| 502 | T-Cell Lymphoma | 0.8% |
| 503 | Mantle cell lymphoma | 0.8% |
| 504 | Anus Neoplasms | 0.7% |
| 505 | Sigmoid Neoplasms | 0.7% |
| 506 | Mastocytoma | 0.7% |
| 507 | Mastocytosis, Systemic | 0.7% |
| 508 | Leukemia, Myeloid, Chronic-Phase | 0.7% |
| 509 | Fibromatosis, Aggressive | 0.6% |
| 510 | Fibromatosis, Abdominal | 0.6% |
| 511 | Klatskin Tumor | 0.6% |
| 512 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.5% |
| 513 | Leukemia, Large Granular Lymphocytic | 0.5% |
| 514 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.5% |
| 515 | Lymphoma, T-Cell, Cutaneous | 0.5% |
| 516 | Lymphoma, AIDS-Related | 0.5% |
| 517 | Enteropathy-Associated T-Cell Lymphoma | 0.5% |
| 518 | Primary Effusion Lymphoma | 0.5% |
| 519 | Dupuytren Contracture | 0.4% |
| 520 | Urticaria Pigmentosa | 0.4% |
| 521 | Burkitt Lymphoma | 0.4% |
| 522 | Mycosis Fungoides | 0.4% |
| 523 | Lymphomatoid Papulosis | 0.4% |
| 524 | Plasmablastic lymphoma | 0.4% |
| 525 | Sezary Syndrome | 0.3% |
| 526 | Radicular Cyst | 0.3% |